Teresa Infante

Teresa Infante

Auto-generated profile, based on publicly available information

Teresa Infante

IRCCS SDN, Naples, Italy

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in JACC
Verified
Journal Article
Closed access
CNCLAUDIO NAPOLI
CLAUDIO NAPOLI
Giuseppe PaolissoGiuseppe Paolisso
Giuseppe Paolisso
Amelia CasamassimiAmelia Casamassimi
Amelia Casamassimi
MAMohammed Al-Omran
Mohammed Al-Omran
MBMichelangela Barbieri
Michelangela Barbieri
LILouis J. Ignarro
Louis J. Ignarro

Verified
Journal Article
Open access
PDF file
MIMariarosaria Incoronato
Mariarosaria Incoronato
MAMarco Aiello
Marco Aiello
TITeresa Infante
Teresa Infante
CCCarlo Cavaliere
Carlo Cavaliere
AGAnna Maria Grimaldi
Anna Maria Grimaldi
MSMarco Salvatore
Marco Salvatore
In the last few years, biomedical research has been boosted by the technological development of analytical instrumentation generating a large volume of data. Such information has increased in complexity from basic (i.e., blood samples) to extensive sets encompassing many aspects of a subject phenotype, and now rapidly extending into genetic and, more recently, radiomic information. Radiogenomics integrates both aspects, investigating the relationship between imaging features and gene expression. From a methodological point of view, radiogenomics takes advantage of non-conventional data analysis techniques that reveal meaningful information for decision-support in cancer diagnosis and treatment. This survey is aimed to review the state-of-the-art techniques employed in radiomics and genomics with special focus on analysis methods based on molecular and multimodal probes. The impact of single and combined techniques will be discussed in light of their suitability in correlation and predictive studies of specific oncologic diseases.

15 May 2012 in Circulation
Verified
Journal Article
Closed access
PDF file
CNCLAUDIO NAPOLI
CLAUDIO NAPOLI
VCValeria Crudele
Valeria Crudele
ASAndrea Soricelli
Andrea Soricelli
MAMohammed Al-Omran
Mohammed Al-Omran
NVNicoletta Vitale
Nicoletta Vitale
FMFrancesco P. Mancini
Francesco P. Mancini
Innovative advances in understanding the pathogenesis of atherosclerosis have been achieved over the past 25 years. Although elevated levels of serum low-density lipoprotein cholesterol (LDL-C) are the major cause of onset of the disease, as established by a large number of superb epidemiological, clinical, and experimental studies, important novel factors have entered the arena of the atherogenic process. Besides the historical oxidative hypothesis that states that oxidized LDL, by escaping the homeostatic mechanism, strongly accelerates plaque formation, more recent evidence has given credit to vascular inflammation and apoptosis as crucial players in the progression of atherosclerosis.1–3 The disease has also been linked to the subintimal infiltration of immune cells and endothelial dysfunction induced by cardiovascular risk factors. Currently, endothelial dysfunction is considered one of the first stages of vascular damage and an early event in atherogenesis.1–3 Etiologic and pathogenetic factors, of both genetic and environmental origin, act together to promote local and systemic effects that lead to the onset, progression, and final outcome of the atherosclerotic disease. The clinical sequelae of atherosclerosis, myocardial infarction, stroke, and peripheral arterial disease depend on the affected vascular district, which in turn depends on complex gene-environment interplay. Despite the sudden occurrence of clinical symptoms, however, the evolution of atherosclerosis is very slow, which provides an opportunity for early diagnosis. In fact, a breakthrough in the field has been to recognize that although atherosclerosis generates severe diseases that most frequently affect middle-aged to old people, atherogenesis begins very early in life, even at the fetal stage.4,5 Primary prevention of any disease is more effective if started sooner. Therefore, it is of paramount importance to identify high-risk individuals and to initiate primary prevention in a timely manner, especially for atherosclerosis, which can begin its slow but relentless …

1 December 2012 in European Journal of Preventive Cardiology
Verified
Journal Article
Closed access
PDF file
FCFrancesco Cacciatore
Francesco Cacciatore
PAPasquale Abete
Pasquale Abete
FMFrancesca Mazzella
Francesca Mazzella
GFGiuseppe Furgi
Giuseppe Furgi
ANAntonio Nicolino
Antonio Nicolino
FRFranco Rengo
Franco Rengo
Background: Age-related effects on the ability of 6-min walking test (6MWT) and ejection fraction (EF) to predict mortality in coronary artery bypass grafting (CABG) patients undergoing cardiac rehabilitation (CR) is still debated.

20 April 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Valerio CostaValerio Costa
Valerio Costa
Claudia AngeliniClaudia Angelini
Claudia Angelini
LDLuciana D'Apice
Luciana D'Apice
MMMargherita Mutarelli
Margherita Mutarelli
Amelia CasamassimiAmelia Casamassimi
Amelia Casamassimi
Alfredo CiccodicolaAlfredo Ciccodicola
Alfredo Ciccodicola
Hybridization- and tag-based technologies have been successfully used in Down syndrome to identify genes involved in various aspects of the pathogenesis. However, these technologies suffer from several limits and drawbacks and, to date, information about rare, even though relevant, RNA species such as long and small non-coding RNAs, is completely missing. Indeed, none of published works has still described the whole transcriptional landscape of Down syndrome. Although the recent advances in high-throughput RNA sequencing have revealed the complexity of transcriptomes, most of them rely on polyA enrichment protocols, able to detect only a small fraction of total RNA content. On the opposite end, massive-scale RNA sequencing on rRNA-depleted samples allows the survey of the complete set of coding and non-coding RNA species, now emerging as novel contributors to pathogenic mechanisms. Hence, in this work we analysed for the first time the complete transcriptome of human trisomic endothelial progenitor cells to an unprecedented level of resolution and sensitivity by RNA-sequencing. Our analysis allowed us to detect differential expression of even low expressed genes crucial for the pathogenesis, to disclose novel regions of active transcription outside yet annotated loci, and to investigate a plethora of non-polyadenilated long as well as short non coding RNAs. Novel splice isoforms for a large subset of crucial genes, and novel extended untranslated regions for known genes—possibly novel miRNA targets or regulatory sites for gene transcription—were also identified in this study. Coupling the rRNA depletion of samples, followed by high-throughput RNA-sequencing, to the easy availability of these cells renders this approach very feasible for transcriptome studies, offering the possibility of investigating in-depth blood-related pathological features of Down syndrome, as well as other genetic disorders.

29 March 2011 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
FCFrancesco Cacciatore
Francesco Cacciatore
GBGiuseppe Bruzzese
Giuseppe Bruzzese
DVDino Franco Vitale
Dino Franco Vitale
ALAntonio Liguori
Antonio Liguori
FNFilomena de Nigris
Filomena de Nigris
CNCLAUDIO NAPOLI
CLAUDIO NAPOLI